NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

Go back to NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
(NASDAQ: NRXP) Delayed: 3.95 +0.08 (2.07%)
Previous Close $3.87    52 Week High
Open $3.90    52 Week Low
Day High $3.96    P/E N/A 
Day Low $3.80    EPS
Volume 620,497